Should Drug Manufacturers - Specialty & Generic Stock Organogenesis Holdings Inc (ORGO) Be in Your Portfolio Thursday?

Thursday, October 07, 2021 10:29 AM | InvestorsObserver Analysts

Mentioned in this article

A rating of 91 puts Organogenesis Holdings Inc (ORGO) near the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. Organogenesis Holdings Inc's score of 91 means it scores higher than 91% of stocks in the industry. Organogenesis Holdings Inc also received an overall rating of 51, putting it above 51% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 140 out of the 148 industries.

ORGO has an Overall Score of 51. Find out what this means to you and get the rest of the rankings on ORGO!
See Full ORGO Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Organogenesis Holdings Inc Stock Today?

Organogenesis Holdings Inc (ORGO) stock is lower by -6.05% while the S&P 500 is higher by 1.46% as of 10:29 AM on Thursday, Oct 7. ORGO has fallen -$0.79 from the previous closing price of $13.05 on volume of 168,121 shares. Over the past year the S&P 500 is up 29.47% while ORGO is higher by 210.38%. ORGO earned $0.56 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 21.7. Click Here to get the full Stock Report for Organogenesis Holdings Inc stock.

Share this article:

Related Articles